News Room

Recap, Legal Analysis, and What’s to Come

Akebia Therapeutics: Waiting For Round 2 (NASDAQ:AKBA)

Orange-juice futures suffer their biggest weekly decline in over 6 years after hitting record

Short-term bonds dominate fixed-income ETF flows again in October — with a single fund getting outsize portion of investors’ money

JPMorgan’s Dimon criticizes Texas laws, firm remains committed despite bond deal disruptions

Hardship May Soon Be Basis For New Biden Student Loan Forgiveness Plan

Apple issues cautious revenue outlook for the holiday quarter. How to play the stock

Saudi Arabia’s oil production cuts have tipped its economy into reverse

DeFi Protocol SafeMoon Still Running Despite Securities Violations

Credicorp Ltd. (BAP) Q3 2023 Earnings Conference Call Transcript